Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Debt to Equity (2019 - 2025)

Pulmonx (LUNG) has disclosed Debt to Equity for 6 consecutive years, with $0.54 as the latest value for Q2 2025.

  • On a quarterly basis, Debt to Equity rose 46.11% to $0.54 in Q2 2025 year-over-year; TTM through Jun 2025 was $0.54, a 46.11% increase, with the full-year FY2024 number at $0.43, up 37.64% from a year prior.
  • Debt to Equity was $0.54 for Q2 2025 at Pulmonx, up from $0.48 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.54 in Q2 2025 to a low of $0.0 in Q4 2021.
  • A 5-year average of $0.23 and a median of $0.26 in 2023 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: skyrocketed 7950.79% in 2022, then soared 30.15% in 2024.
  • Pulmonx's Debt to Equity stood at $0.0 in 2021, then surged by 7950.79% to $0.11 in 2022, then soared by 179.84% to $0.31 in 2023, then surged by 37.64% to $0.43 in 2024, then rose by 23.99% to $0.54 in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Debt to Equity are $0.54 (Q2 2025), $0.48 (Q1 2025), and $0.43 (Q4 2024).